Cosmetic Dermatology of Orange County
Dermatology
Dr. Cheryl L. Effron is an expert in the field of Dermatology. He researched medicine at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31 in research and 72 in primary care medicine He over the years received 1 awards: "Fellow (FAAD)". Cheryl Effron is also published. He has 2 publications published. The lastest publication: "The use of fillers and botulinum toxin type A in combination with superficial glycolic acid (alpha-hydroxy acid) peels: optimizing injection therapy with the skin-smoo...' Cheryl Effron is registered with Medicare and accepts Medicare payments.
Publications
Schools
Keck Sch Of Med Of The Usc
Va Long Beach Hlthcare Sys
Stanford University
Procedures Preformed
- Acne Surgery
- Biopsy
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- View All
Conditions Treated
- Acne
- Acne Vulgaris
- Actinic Keratosis
- Athlete's Foot
- View All
Doctors Specialties
- Dermatology
- Pediatric Dermatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of California PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Medicare HMO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
Education
-
Keck School of Medicine of USC
Drug Facts
NPI NUMBER |
|
1861425845 |
NPPES Provider LastName |
|
EFFRON |
NPPES Provider FirstName |
|
CHERYL |
NPPES Provider ZIPCode |
|
928074759 |
NPPES Provider State |
|
CA |
Specialty Description |
|
Dermatology |
Total Claim Count |
|
1080.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1861425845 |
Last Name Of The Provider |
EFFRON |
First Name Of The Provider |
CHERYL |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog